14 results
424B3
XBP
XBP Europe Holdings Inc
13 Feb 24
Prospectus supplement
4:31pm
.
Research and Development
The Company’s ability to compete successfully depends heavily upon its ability to ensure a timely flow of competitive products … of Presentation and Summary of Significant Accounting Policies (cont.)
Research and Development
Research and development costs are expensed as incurred
424B5
x4uco3vwyx zwocyu0t
29 Nov 23
Prospectus supplement for primary offering
4:44pm
CORRESP
gd4alozxm5
12 May 23
Correspondence with SEC
12:00am
425
EX-2.1
gntseps5 ana9e
11 Oct 22
Business combination disclosure
6:07am
8-K
EX-2.1
20jdhl
11 Oct 22
Exela Technologies Inc.’s European business to go Public Through Merger with CF Acquisition Corp. VIII
6:05am
- Prev
- 1
- Next